rdf:type |
|
lifeskim:mentions |
umls-concept:C0003009,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0086418,
umls-concept:C0597357,
umls-concept:C0919289,
umls-concept:C1042324,
umls-concept:C1167622,
umls-concept:C1412113,
umls-concept:C1533691,
umls-concept:C2700441
|
pubmed:issue |
12
|
pubmed:dateCreated |
2002-12-20
|
pubmed:abstractText |
A bioassay-guided fractionation of the 70% acetone extract of the bark of Guazuma ulmifolia Lam. on the inhibition of angiotensin II binding to the AT 1 receptor led to the isolation and identification of bioactive oligomeric and polymeric proanthocyanidins consisting mainly of (-)-epicatechin units. The displacement of [3H]-angiotensin II binding was dose-dependent and correlated with the degree of polymerization of the different fractions containing proanthocyanidins. A strong displacement was seen for the residual fraction suggesting that the most active substances corresponding to the highly polymerized proanthocyanidins. Angiotensin II AT 1 receptor binding might be considered as a potentially interesting biological activity of proanthocyanidins contributing to the very broad spectrum of biological activities of the condensed tannins.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Anthocyanins,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Extracts,
http://linkedlifedata.com/resource/pubmed/chemical/Proanthocyanidins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Angiotensin,
http://linkedlifedata.com/resource/pubmed/chemical/Tritium,
http://linkedlifedata.com/resource/pubmed/chemical/proanthocyanidin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0032-0943
|
pubmed:author |
pubmed-author:Caballero-GeorgeCatherinaC,
pubmed-author:ClaeysMagdaM,
pubmed-author:De BruyneTessT,
pubmed-author:GuptaMahabir PMP,
pubmed-author:PietersLucL,
pubmed-author:ShahatAbdel-AttyAA,
pubmed-author:SolisPablo NPN,
pubmed-author:Van den HeuvelHildeH,
pubmed-author:VanderheydenPatrick M LPM,
pubmed-author:VauquelinGeorgesG,
pubmed-author:VlietinckArnold JAJ
|
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1066-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12494331-Angiotensin II,
pubmed-meshheading:12494331-Anthocyanins,
pubmed-meshheading:12494331-Binding, Competitive,
pubmed-meshheading:12494331-Binding Sites,
pubmed-meshheading:12494331-Dose-Response Relationship, Drug,
pubmed-meshheading:12494331-Humans,
pubmed-meshheading:12494331-Malvaceae,
pubmed-meshheading:12494331-Plant Bark,
pubmed-meshheading:12494331-Plant Extracts,
pubmed-meshheading:12494331-Proanthocyanidins,
pubmed-meshheading:12494331-Receptor, Angiotensin, Type 1,
pubmed-meshheading:12494331-Receptors, Angiotensin,
pubmed-meshheading:12494331-Tritium
|
pubmed:year |
2002
|
pubmed:articleTitle |
In vitro inhibition of [3H]-angiotensin II binding on the human AT1 receptor by proanthocyanidins from Guazuma ulmifolia bark.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|